BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 35010633)

  • 21. Inflammation enhances Y1 receptor signaling, neuropeptide Y-mediated inhibition of hyperalgesia, and substance P release from primary afferent neurons.
    Taylor BK; Fu W; Kuphal KE; Stiller CO; Winter MK; Chen W; Corder GF; Urban JH; McCarson KE; Marvizon JC
    Neuroscience; 2014 Jan; 256():178-94. PubMed ID: 24184981
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inflammation and Organ Injury the Role of Substance P and Its Receptors.
    Zhu Z; Bhatia M
    Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047113
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of neurogenic substance P in overexpression of alveolar macrophages' neurokinin 1 receptor in mice exposed to cigarette smoke.
    Xu J; Xu F
    Exp Lung Res; 2010 May; 36(4):243-54. PubMed ID: 20426532
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Increased expressions of substance P and neurokinin/tachykinin receptor 1 in eosinophils of patients with psoriasis].
    Zuo Z; Wang J; Zhang H; Zheng W; Zhang Z; He S
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2017 Jul; 33(7):966-970. PubMed ID: 28712406
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Normative distribution of substance P and its tachykinin neurokinin-1 receptor in the medullary serotonergic network of the human infant during postnatal development.
    Bright FM; Byard RW; Vink R; Paterson DS
    Brain Res Bull; 2018 Mar; 137():319-328. PubMed ID: 29331576
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunolocalization of Substance P and NK-1 Receptor in ADIPOSE Stem Cells.
    Muñoz M; Muñoz MF; Ayala A
    J Cell Biochem; 2017 Dec; 118(12):4686-4696. PubMed ID: 28500728
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overexpression of membrane metalloendopeptidase inhibits substance P stimulation of cholangiocarcinoma growth.
    Meng F; DeMorrow S; Venter J; Frampton G; Han Y; Francis H; Standeford H; Avila S; McDaniel K; McMillin M; Afroze S; Guerrier M; Quezada M; Ray D; Kennedy L; Hargrove L; Glaser S; Alpini G
    Am J Physiol Gastrointest Liver Physiol; 2014 May; 306(9):G759-68. PubMed ID: 24603459
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of substance P, neurokinin-1 receptor and immune markers in the brains of individuals with HIV-associated neuropathology.
    Spitsin S; Stevens KE; Douglas SD
    J Neurol Sci; 2013 Nov; 334(1-2):18-23. PubMed ID: 23916293
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Substance P Receptor Antagonist Suppresses Inflammatory Cytokine Expression in Human Disc Cells.
    Kepler CK; Markova DZ; Koerner JD; Mendelis J; Chen CM; Vaccaro AR; Risbud MV; Albert TJ; Anderson DG
    Spine (Phila Pa 1976); 2015 Aug; 40(16):1261-9. PubMed ID: 25929203
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High expression of substance P and its receptor neurokinin-1 receptor in colorectal cancer is associated with tumor progression and prognosis.
    Chen XY; Ru GQ; Ma YY; Xie J; Chen WY; Wang HJ; Wang SB; Li L; Jin KT; He XL; Mou XZ
    Onco Targets Ther; 2016; 9():3595-602. PubMed ID: 27366097
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation of neurokinin-1 receptors up-regulates substance P and neurokinin-1 receptor expression in murine pancreatic acinar cells.
    Koh YH; Moochhala S; Bhatia M
    J Cell Mol Med; 2012 Jul; 16(7):1582-92. PubMed ID: 22040127
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of different neurokinin-1 receptor (NK1R) isoforms in glioblastoma multiforme: potential implications for targeted therapy.
    Cordier D; Gerber A; Kluba C; Bauman A; Hutter G; Mindt TL; Mariani L
    Cancer Biother Radiopharm; 2014 Jun; 29(5):221-6. PubMed ID: 24552486
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Truncation of neurokinin-1 receptor-Negative regulation of substance P signaling.
    Spitsin S; Pappa V; Douglas SD
    J Leukoc Biol; 2018 Jan; ():. PubMed ID: 29345372
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neurokinin-1 receptor expression and function in human macrophages and brain: perspective on the role in HIV neuropathogenesis.
    Douglas SD; Lai JP; Tuluc F; Schwartz L; Kilpatrick LE
    Ann N Y Acad Sci; 2008 Nov; 1144():90-6. PubMed ID: 19076368
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of substance P in the marginal division of the neostriatum in learning and memory is mediated through the neurokinin 1 receptor in rats.
    Liu XM; Shu SY; Zeng CC; Cai YF; Zhang KH; Wang CX; Fang J
    Neurochem Res; 2011 Oct; 36(10):1896-902. PubMed ID: 21611833
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Localization of neurokinin 1 receptor (NK1R) immunoreactivity in rat esophagus.
    Kuramoto H; Oomori Y; Murabayashi H; Kadowaki M; Karaki S; Kuwahara A
    J Comp Neurol; 2004 Oct; 478(1):11-21. PubMed ID: 15334646
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuropeptide Substance P Enhances Inflammation-Mediated Tumor Signaling Pathways and Migration and Proliferation of Head and Neck Cancers.
    Singh S; Kumaravel S; Dhole S; Roy S; Pavan V; Chakraborty S
    Indian J Surg Oncol; 2021 Apr; 12(Suppl 1):93-102. PubMed ID: 33994734
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The redox modulatory effects of SP/NK1R system: Implications for oxidative stress-associated disorders.
    Ebrahimi S; Alalikhan A; Aghaee-Bakhtiari SH; Hashemy SI
    Life Sci; 2022 May; 296():120448. PubMed ID: 35247438
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Substance P (SP) enhances CCL5-induced chemotaxis and intracellular signaling in human monocytes, which express the truncated neurokinin-1 receptor (NK1R).
    Chernova I; Lai JP; Li H; Schwartz L; Tuluc F; Korchak HM; Douglas SD; Kilpatrick LE
    J Leukoc Biol; 2009 Jan; 85(1):154-64. PubMed ID: 18835883
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Corneal lymphangiogenesis in dry eye disease is regulated by substance P/neurokinin-1 receptor system through controlling expression of vascular endothelial growth factor receptor 3.
    Lee SJ; Im ST; Wu J; Cho CS; Jo DH; Chen Y; Dana R; Kim JH; Lee SM
    Ocul Surf; 2021 Oct; 22():72-79. PubMed ID: 34311077
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.